Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
12.15
-0.40 (-3.19%)
At close: Mar 28, 2025, 4:00 PM
12.53
+0.38 (3.16%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $922.02 million as of March 28, 2025. Its market cap has increased by 30.23% in one year.
Market Cap
922.02M
Enterprise Value
340.74M
1-Year Change
30.23%
Ranking
Category
Stock Price
$12.15
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $922.02M, an increase of 30.95%. That is a compound annual growth rate of 5.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 922.02M | -30.91% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | 1.28B | 81.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |